1. Home
  2. RGEN vs WAL Comparison

RGEN vs WAL Comparison

Compare RGEN & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$114.18

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$68.10

Market Cap

9.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGEN
WAL
Founded
1981
1994
Country
United States
United States
Employees
N/A
3524
Industry
Medical/Dental Instruments
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
9.6B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
RGEN
WAL
Price
$114.18
$68.10
Analyst Decision
Buy
Buy
Analyst Count
11
16
Target Price
$173.09
$98.40
AVG Volume (30 Days)
819.7K
1.8M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
2.47%
EPS Growth
286.96
N/A
EPS
0.86
N/A
Revenue
$141,236,000.00
N/A
Revenue This Year
$14.11
$20.16
Revenue Next Year
$14.71
$8.63
P/E Ratio
$132.19
$10.88
Revenue Growth
35.10
N/A
52 Week Low
$102.97
$57.05
52 Week High
$175.77
$97.23

Technical Indicators

Market Signals
Indicator
RGEN
WAL
Relative Strength Index (RSI) 28.92 24.51
Support Level $113.07 N/A
Resistance Level $132.51 $79.68
Average True Range (ATR) 6.42 3.35
MACD -0.57 -1.83
Stochastic Oscillator 6.23 2.92

Price Performance

Historical Comparison
RGEN
WAL

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: